PubMed چکیده/رکورد

Mitochondrial fission dictates pro-survival adaptation and irreversible demise in oral cancer.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Mitochondrial fission is dynamically balanced with fusion, which is essential for maintaining cellular energy homeostasis and metabolic plasticity. In oral cancer, (of which over 90% is oral squamous cell carcinoma; OSCC) accumulating evidence highlights that dysregulated mitochondrial fission is intimately linked to high-grade malignancy, metastatic propensity, and acquired chemoresistance. Notably, mitochondrial fission exhibits a striking functional dichotomy in this context. On the one hand, oncogenic sustained excessive fragmentation supports elevated metabolic demands and facilitates tumor progression by coupling fission to protective mitophagy and cellular motility. Conversely, under therapeutic pressure from genotoxic agents, the same fission machinery can be exploited to trigger lethal mitophagy and intrinsic apoptosis. However, the precise molecular mechanisms by which the fission machinery deciphers distinct upstream signals dictates these divergent pro-survival versus pro-death outcomes remain insufficiently understood. Moreover, the impact of spatial heterogeneity of fission events, specifically the distinction between proliferative midzone fission and degradative peripheral fission, on therapeutic response is largely unexplored. This review systematically dissects the context-dependent plasticity of mitochondrial fission in oral cancer and provides a unified mechanistic framework to reconcile existing contradictions. We further propose that strategically disrupting the dynamic equilibrium of mitochondria may overcome drug resistance and reshape therapeutic outcomes in OSCC, with potential extrapolation to other oral cancer subtypes.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Drug resistanceMitochondrial fissionMitophagyOral cancer
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Adverse reactions and safety of nebulized budesonide in elderly patients with inflammatory airway diseases.

BACKGROUND: Budesonide suspension is a first-line inhaled corticosteroid for elderly patients with inflammatory airway diseases, but existing research lacks targeted safety data for the very elderly (≥80 years), systematic analysis of adverse reaction (ADR) temporal distribution and quantitative evidence for modifiable clinical risk factors. OBJECTIVE: To investigate the safety profile, ADR temporal patterns and independent modifiable …

PubMed2026

Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma-Innovation and Insights.

Oral cavity squamous cell carcinoma (OCSCC) represents the 16th most prevalent cancer worldwide accounting for greater than 389,000 cases annually. Most examples of OCSCC are preceded by a diverse group of lesions exhibiting variable risk of transformation to cancer, collectively termed oral potentially malignant disorders (OPMDs). The identification of salivary, serologic, and/or tumor tissue biomarkers holds substantial promise for i…

PubMed2026

Chronic Oral Complications of Oral Cancer Therapy.

Head and neck cancer (HNC) patients are uniquely susceptible to adverse oral health outcomes following head and neck radiation therapy (RT). Various risk factors for these oral health outcomes post-RT were identified in the OraRad study, which followed HNC patients from pre-RT to 2 y post-RT. Chronic oral complications include hyposalivation, trismus, dental caries, periodontal disease, tooth loss, exposed bone, and osteoradionecrosis …

PubMed2026

Diagnostic Adjuncts and Biopsy Techniques for Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma.

Diagnostic adjuncts for oral potentially malignant disorders such as leukoplakia or erythroplakia can aid the clinician in triaging abnormal lesions and facilitate both biopsy site selection and surgical management. No adjuncts replace gold standard biopsy and histopathological examination, and their optimal use requires training and experience. This article covers the potential applications, both in primary and expert settings, of adj…